CO6260068A2 - Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil)tiazolil)carbonil)piperidina - Google Patents
Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil)tiazolil)carbonil)piperidinaInfo
- Publication number
- CO6260068A2 CO6260068A2 CO10030406A CO10030406A CO6260068A2 CO 6260068 A2 CO6260068 A2 CO 6260068A2 CO 10030406 A CO10030406 A CO 10030406A CO 10030406 A CO10030406 A CO 10030406A CO 6260068 A2 CO6260068 A2 CO 6260068A2
- Authority
- CO
- Colombia
- Prior art keywords
- fluorophenyl
- piperidine
- methyl
- polymorphic forms
- carbonilaminometil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Nuevas formas polimórficas de (S)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil))tiazolil)carbonil)piperidina, métodos para su preparación y uso en medicina. 1.- Una forma polimórfica de (S)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil))tiazolil)carbonil)piperidina (Forma 1) caracterizada por que: i) proporciona un difractograma de difracción de rayos X de polvo (XRPD) que comprende los siguientes picos: yii) tiene un comienzo de fusión en el intervalo de 163-173°C, tal como se midió mediante análisis por DSC. 2.- Un polimorfo de acuerdo con la reivindicación 1, caracterizado además por que proporciona un patrón de difracción de rayos X de polvo (XRPD) sustancialmente de acuerdo con la Figura 7.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0717882.5A GB0717882D0 (en) | 2007-09-13 | 2007-09-13 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6260068A2 true CO6260068A2 (es) | 2011-03-22 |
Family
ID=38658914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10030406A CO6260068A2 (es) | 2007-09-13 | 2010-03-15 | Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil)tiazolil)carbonil)piperidina |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20100286201A1 (es) |
| EP (1) | EP2190842A1 (es) |
| JP (1) | JP2010539133A (es) |
| KR (1) | KR20100057035A (es) |
| CN (1) | CN101801968A (es) |
| AR (1) | AR068414A1 (es) |
| AU (1) | AU2008297126A1 (es) |
| BR (1) | BRPI0816757A2 (es) |
| CA (1) | CA2699472A1 (es) |
| CL (1) | CL2008002688A1 (es) |
| CO (1) | CO6260068A2 (es) |
| CR (1) | CR11306A (es) |
| DO (1) | DOP2010000066A (es) |
| EA (1) | EA201070361A1 (es) |
| GB (1) | GB0717882D0 (es) |
| MA (1) | MA31692B1 (es) |
| MX (1) | MX2010002895A (es) |
| PE (1) | PE20090639A1 (es) |
| TW (1) | TW200927748A (es) |
| UY (1) | UY31337A1 (es) |
| WO (1) | WO2009034133A1 (es) |
| ZA (1) | ZA201001083B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120101110A1 (en) * | 2010-10-26 | 2012-04-26 | Sangamesh Badiger | Diaza-spiro[5.5]undecanes |
| WO2017194548A1 (en) | 2016-05-10 | 2017-11-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2238458T3 (es) * | 2000-06-16 | 2005-09-01 | Smithkline Beecham Plc | Piperidinas para uso como antagonistas de los receptores de orexina. |
| WO2006081522A2 (en) * | 2005-01-26 | 2006-08-03 | The Regents Of The Unversity Of California | Modulation of nmda receptor currents via orexin receptor and/or crf receptor |
-
2007
- 2007-09-13 GB GBGB0717882.5A patent/GB0717882D0/en not_active Ceased
-
2008
- 2008-09-10 CL CL2008002688A patent/CL2008002688A1/es unknown
- 2008-09-11 KR KR1020107005447A patent/KR20100057035A/ko not_active Application Discontinuation
- 2008-09-11 EP EP08804029A patent/EP2190842A1/en not_active Withdrawn
- 2008-09-11 JP JP2010524487A patent/JP2010539133A/ja not_active Withdrawn
- 2008-09-11 UY UY31337A patent/UY31337A1/es unknown
- 2008-09-11 US US12/677,614 patent/US20100286201A1/en not_active Abandoned
- 2008-09-11 EA EA201070361A patent/EA201070361A1/ru unknown
- 2008-09-11 AR ARP080103950A patent/AR068414A1/es not_active Application Discontinuation
- 2008-09-11 WO PCT/EP2008/062064 patent/WO2009034133A1/en active Application Filing
- 2008-09-11 MX MX2010002895A patent/MX2010002895A/es unknown
- 2008-09-11 BR BRPI0816757 patent/BRPI0816757A2/pt not_active IP Right Cessation
- 2008-09-11 PE PE2008001590A patent/PE20090639A1/es not_active Application Discontinuation
- 2008-09-11 AU AU2008297126A patent/AU2008297126A1/en not_active Abandoned
- 2008-09-11 TW TW097134783A patent/TW200927748A/zh unknown
- 2008-09-11 CN CN200880106870A patent/CN101801968A/zh active Pending
- 2008-09-11 CA CA2699472A patent/CA2699472A1/en not_active Abandoned
-
2010
- 2010-02-15 ZA ZA201001083A patent/ZA201001083B/xx unknown
- 2010-02-26 DO DO2010000066A patent/DOP2010000066A/es unknown
- 2010-03-05 MA MA32671A patent/MA31692B1/fr unknown
- 2010-03-10 CR CR11306A patent/CR11306A/es unknown
- 2010-03-15 CO CO10030406A patent/CO6260068A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR068414A1 (es) | 2009-11-18 |
| JP2010539133A (ja) | 2010-12-16 |
| UY31337A1 (es) | 2009-04-30 |
| WO2009034133A1 (en) | 2009-03-19 |
| GB0717882D0 (en) | 2007-10-24 |
| EP2190842A1 (en) | 2010-06-02 |
| CA2699472A1 (en) | 2009-03-19 |
| MX2010002895A (es) | 2010-04-01 |
| TW200927748A (en) | 2009-07-01 |
| CL2008002688A1 (es) | 2009-11-27 |
| CN101801968A (zh) | 2010-08-11 |
| CR11306A (es) | 2010-04-20 |
| MA31692B1 (fr) | 2010-09-01 |
| EA201070361A1 (ru) | 2010-08-30 |
| KR20100057035A (ko) | 2010-05-28 |
| ZA201001083B (en) | 2010-10-27 |
| BRPI0816757A2 (pt) | 2015-03-17 |
| PE20090639A1 (es) | 2009-06-25 |
| US20100286201A1 (en) | 2010-11-11 |
| DOP2010000066A (es) | 2010-04-15 |
| AU2008297126A1 (en) | 2009-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR077203A1 (es) | Forma polimorfica d del acetato de bazedoxifeno, composiciones farmaceuticas que la contienen metodo para prepararla y uso del mismo para tratar enfermedades mediadas por moduladores selectivos de receptores estrogenicos (serms) | |
| PE20120812A1 (es) | Compuestos vinil indazolilo | |
| ES2540852T3 (es) | Cristal de sal de 4-(3-cloro-4-(ciclopropilaminocarbonil)aminofenoxi)-7-metoxi-6-quinolincarboxamida o de su solvato, y procedimientos para producir estos | |
| CL2010001348A1 (es) | Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad. | |
| CL2004000917A1 (es) | Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa | |
| BR112012018345A2 (pt) | "compostos de heteroarila, bem como composições e usos dos mesmos" | |
| CL2012002944A1 (es) | Compuestos derivados de amino-pirimidinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
| CL2012002945A1 (es) | Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
| NI201000179A (es) | Pirimidin-5-carboxamidas sustituidas 281 | |
| UY31940A (es) | Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones | |
| UY33921A (es) | Oxazinopteridinas y oxazinoptiridinonas n-sustituidas | |
| AR096759A1 (es) | Formas sólidas de un inhibidor de quinasa macrocíclica | |
| UY31219A1 (es) | N-[3-(2,6-diclorofenil)-5-alquilo-1,2-oxazol-4-il carbamatos sustituidos y 1-[3-(2,6-diclorofenil)-5-metil-1,2-oxazol-4-il]ureas sustituidas asi como isomeros, sales farmacéuticas y usos de dichos compuestos | |
| CO6410293A2 (es) | Nueva formula cristalina vi de la agomelatina preparación y uso de la misma | |
| ES2570374T3 (es) | Antagonistas del receptor opioide periférico y usos de los mismos | |
| ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
| CO6251360A2 (es) | Bromhidrato de bupropion y aplicaciones terapeuticas | |
| UY29896A1 (es) | Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
| MA34055B1 (fr) | Chlorhydrate d'agomelatine hydrate et sa preparation | |
| AR065119A1 (es) | Compuesto de 2- oxo-1-oxa-3-azaespiro (4,5) decan-3-ilo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende | |
| CO6321280A2 (es) | Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
| WO2010066810A8 (en) | Transdermal pharmaceutical compositions comprising a serm | |
| UA112764C2 (uk) | Оптимізований синтез чистих, неполіморфних кристалічних жовчних кислот із заданим розміром частинок | |
| UY30121A1 (es) | Nuevos compuestos | |
| CO6260068A2 (es) | Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil)tiazolil)carbonil)piperidina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |